Coronavirus updates

COVID-19 latest information from AXA Investment Managers

Since January, we have been closely monitoring the global progression of the COVID-19 virus, and have progressively implemented measures intended to safeguard our employees’ health and safety and the continuity of our business.  AXA IM’s management team is fully mobilised to address any issue COVID-19 may cause and is acting accordingly.

Following the recent decisions of various governments, we have decided to implement a new set of measures, which will lead most of our staff, across our different offices, to work remotely, or in an alternate team mode for a limited number of teams.

Those tested measures are part of our Business Continuity Plan (“BCP”), and we are consequently confident in our ability to maintain an equivalent level of services in this extended remote mode.

Please also be assured that these uncertain times have not affected our dedication or commitment to provide you with the best quality of services.

We will of course keep you informed of any further action that would be deemed appropriate to ensure the continuity of our business and to maximize the personal safety of our employees, clients and partners. You can stay up to date with our expert views of the situation, and the impact on the markets, by following us on social media and visiting this page of our website. You will find below all the latest insights and research articles related to Coronavirus.

We wish you, your families and loved ones, and everyone at your company, good health.

- Access to our INSIGHTS HUB section with all our insights –

 

Insights

Market thinking

02 April 2020

COVID-19 Impact: AXA IM’s macroeconomic and investment strategy update

The COVID-19 crisis continues to cause significant volatility

Podcast

01 April 2020

Macrocast podcast #1 - Mutualise or Trust the Printing Press

Every Monday, Gilles Moëc demystifies a hot topic from his Macrocast newsletter in a 10-minute podcast.

Tomorrow Augmented

01 April 2020

Is a vaccine for coronavirus on its way, and what are the challenges?

Peter Hughes, PhD, Fund Manager, Healthcare Strategies at AXA IM, gives his view on the current trials to develop vaccines and treatments for COVID-19, and what the challenges – and next steps ...

Macrocast

30 March 2020

Mutualise or Trust the Printing Press

Our baseline of a 2 to 3% shock to GDP may be optimistic given the time it takes for lockdowns to curb the epidemic, especially when taking on board the the hesitant approach favoured by some key cou ...

Market thinking

26 March 2020

COVID-19 Impact: AXA IM’s macroeconomic and investment strategy update

The COVID-19 crisis continues to cause significant volatility. This is an exceptional and defining time for the global economy, but policymakers and central banks are taking decisive action to steady ...

MAI views

24 March 2020

Multi-Asset Investments views – April 2020 – COVID 19 crisis: we have reduced our exposure to risky assets as short-term risk are high

Reduction of equity positioning in the short term - Virus related slow-down in Q2 and Q3 of 2020 is pushing the global economy into recession. Earnings should fall heavily

News

26 March 2020

Congress finally approves $2 trillion stimulus package

Market commentary

David Page, Head of Macro Research at AXA Investment Managers, comments on US Congress’ coronavirus response package: After a couple of weeks of battling, Congress finally agreed on a stimulus packag ...

Read more

22 March 2020

Government introduces measures to backstop the labour force

Market commentary

David Page, Head of Macro Research at AXA Investment Managers, comments on the UK’s latest emergency measures announced during the Covid-19 crisis

Read more

19 March 2020

BoE surprise monetary easing - another day, another policy measure

Market commentary

David Page, Head of Macro Research at AXA Investment Managers, comments on the Bank of England’s second round of monetary easing during the Covid-19 crisis

Read more
Find all news